This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
The Firm is evaluating power morcellator lawsuits on behalf of women who allegedly experienced the spread of uterine sarcoma and other cancers, allegedly caused by the surgical tool used in laparoscopic hysterectomy and fibroid removal surgeries.
New York, NY (PRWEB) July 17, 2014
A nationwide plea to ban power morcellator (http://www.gynecaremorcellatorlawsuit.com/) surgery has taken hold in the U.S., with more than 12,700 signatures now included on a petition inspired by a woman whose uterine cancer allegedly spread because of the device, Bernstein Liebhard LLP reports.
As of July 17th, a total of 12,749 people had signed the Change.org petition, which was created by the husband of a Boston woman who is currently living with stage four uterine leiomyosarcoma she claims to have been spread via a fibroid removal procedure she underwent last October. The couples petition seeks to ban the use of power morcellators from gynecological surgeries in the U.S., in light of concerns that they may promote the dissemination of uterine cancer cells throughout the peritoneal cavity.*
We are pleased to see the issues surrounding power morcellation procedures come to light, as our Firm continues to hear from women whose uterine sarcoma and other cancers allegedly spread after laparoscopic hysterectomy and fibroid removal surgeries aided by the device, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently investigating possible morcellator lawsuits on behalf of women who may have been harmed by the surgical tool.
The issues surrounding power morcellator use have garnered national attention recently, especially after a U.S. Food and Drug Administration (FDA) alert in April that warned of their possible association with the spread of uterine sarcoma and other cancers.
According to the FDA, approximately 1 in every 350 women undergoing fibroid removal surgeries have uterine sarcoma cancer cells that may not have been diagnosed prior to surgery. Uterine sarcoma is almost never discovered until after fibroids have been biopsied, and may ultimately decrease a womans chances of long-term survival, the alert states.
Most recently, the FDAs Obstetrics and Gynecology Devices Panel met to discuss the possible dangers of uterine morcellation at a two-day meeting on July 10th and 11th. More than a dozen women and their families delivered emotional testimonies at the meeting, according to a Boston Globe report, that spoke of cancer-related deaths that allegedly resulted from uterine morcellation. After hearing these testimonies, several of the 15 panelists agreed that the devices should be banned from gynecological surgeries, while others disagreed that they should be removed from the market. All the advisors did agree in the end that women should sign a consent form indicating that they understand the risks of power morcellator surgery, after being fully made aware of safety issues by their doctors.**
Women whose uterine cancer may have spread after a uterine morcellation procedure may be entitled to compensation from the manufacturer of the devices used in their surgery. Learn more about the risks allegedly associated with power morcellators when you visit Bernstein Liebhard LLPs website. Obtain a free and confidential case review by calling 800-511-5092.
*change.org/petitions/women-s-health-alert-deadly-cancers-of-the-uterus-spread-by-gynecologists-stop-morcellating-the-uterus-in-minimally-invasive-and-robot-assisted-hysterectomy, Change.org, July 3, 2014
**bostonglobe.com/lifestyle/health-wellness/2014/07/11/agreement-reached-whether-fda-should-ban-hysterectomy-cutting-tool/EkXZaFAUUnT5HZ7DBQvWbM/story.html, Boston Globe, July 11, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
For the original version on PRWeb visit: http://www.prweb.com/releases/power-morcellator-lawsuit/uterine-sarcoma/prweb12026792.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.